abstract |
The present invention comprises (1) changing a subject's lipid parameter, (2) changing a subject's body composition parameter, (3) treating a pathological condition characterized by bone dysplasia or reduced bone formation in the subject, (4) Improving the daytime awakening and / or cognitive function of the subject, (5) improving the metabolic abnormality of the subject, (6) improving the anabolic effect in the catabolic abnormality of the subject, and / or (7) improving the immune function of the subject and It relates to the use of growth hormone secretagogues (eg GRF or analogues thereof) for reconstruction. [Selection figure] None |